Targeted inhibition of PI3Kα/δ is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCL

類似資料

• CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomas
  著者:: Chen, Linfeng, 等
  出版事項: (2020)
• Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade
  著者:: Chapuy, Bjoern, 等
  出版事項: (2019)
• Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes
  著者:: Scholze, Hanna, 等
  出版事項: (2020)
• The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL
  著者:: Ci, Weimin, 等
  出版事項: (2009)
• HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL
  著者:: Kalac, Matko, 等
  出版事項: (2011)